Antiviral Resistance in Influenza Virus: Mechanism of Action
Weichen Lyu
Abstract
Open-access reader
Weichen Lyu
Abstract
Open-access reader
The "Spanish flu" pandemic caused by H1N1 virus in 1918 caused 50 million deaths. The best-known drugs for treating influenza viruses are antiviral drugs, including amantadine, rimantadine, zanamivir, and oseltamivir. Amantadine and rimantadine are excellent prophylactic drugs against influenza A. Whereas, Zanamivir and oseltamivir have comparable efficacy against influenza A and B viruses. This paper reviews antiviral drugs, approved for clinical use. This review evaluates neuraminidase inhibitors (NAIs), focusing on their mechanism of action and the emergence of resistance to them. The results showed that the viruses mutated and developed resistance during the treatment with NAIs for seasonal, pandemic, and avian influenza
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The "Spanish flu" pandemic caused by H1N1 virus in 1918 caused 50 million deaths. The best-known drugs for treating influenza viruses are antiviral drugs, including amantadine, rimantadine, zanamivir, and oseltamivir. Amantadine and rimantadine are excellent prophylactic drugs against influenza A. Whereas, Zanamivir and oseltamivir have comparable efficacy against influenza A and B viruses. This paper reviews antiviral drugs, approved for clinical use. This review evaluates neuraminidase inhibitors (NAIs), focusing on their mechanism of action and the emergence of resistance to them. The results showed that the viruses mutated and developed resistance during the treatment with NAIs for seasonal, pandemic, and avian influenza
Key concepts: Rimantadine, Zanamivir, Amantadine, Oseltamivir, Neuraminidase, Virology, Neuraminidase inhibitor, Virus